2013 Form 10-K Financial Statement

#000119312514045903 Filed on February 12, 2014

View on sec.gov

Income Statement

Concept 2013 2012 Q4 2012 Q3
Revenue $2.154B $471.3M $473.1M
YoY Change 18.57% 16.4% 16.04%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.580B $340.9M $340.2M
YoY Change 19.25% 18.62% 17.43%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $39.97M $8.091M $7.925M
YoY Change 29.69% 11.35% 27.56%
% of Gross Profit
Operating Expenses $1.702B $368.3M $365.8M
YoY Change 19.26% 17.52% 17.0%
Operating Profit $452.1M $103.0M $107.4M
YoY Change 16.07% 12.58% 12.98%
Interest Expense $5.415M $1.219M $624.0K
YoY Change 66.87% 78.22% -40.91%
% of Operating Profit 1.2% 1.18% 0.58%
Other Income/Expense, Net -$3.719M
YoY Change 175.69%
Pretax Income $448.4M $102.5M $107.2M
YoY Change 15.52% 12.22% 13.63%
Income Tax $167.9M $36.38M $41.26M
% Of Pretax Income 37.44% 35.5% 38.5%
Net Earnings $280.5M $66.10M $65.91M
YoY Change 16.44% 13.27% 13.17%
Net Earnings / Revenue 13.02% 14.03% 13.93%
Basic Earnings Per Share $2.83 $0.67 $0.67
Diluted Earnings Per Share $2.78 $0.66 $0.66
COMMON SHARES
Basic Shares Outstanding 99.11M shares 98.23M shares 97.88M shares
Diluted Shares Outstanding 101.0M shares 100.2M shares 99.62M shares

Balance Sheet

Concept 2013 2012 Q4 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $37.60M $27.90M $71.90M
YoY Change 34.77% 22.91% 67.21%
Cash & Equivalents $31.10M $21.28M $66.12M
Short-Term Investments $6.500M $6.600M $5.800M
Other Short-Term Assets $45.20M $9.228M $6.898M
YoY Change -45.67% 22.53% -91.79%
Inventory
Prepaid Expenses $4.852M $5.149M
Receivables $285.4M $248.1M $250.5M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $368.1M $359.0M $402.8M
YoY Change 2.53% 6.46% 20.6%
LONG-TERM ASSETS
Property, Plant & Equipment $59.90M $59.74M $59.21M
YoY Change 0.34% -1.31% -3.88%
Goodwill $2.166B $1.940B
YoY Change 23.98%
Intangibles
YoY Change
Long-Term Investments $57.50M $47.60M $40.50M
YoY Change 20.8% 5.78% 15.71%
Other Assets $129.4M $118.3M $90.67M
YoY Change 553.54% 42.36% 37.8%
Total Long-Term Assets $2.641B $2.391B $2.130B
YoY Change 10.43% 23.56% 15.41%
TOTAL ASSETS
Total Short-Term Assets $368.1M $359.0M $402.8M
Total Long-Term Assets $2.641B $2.391B $2.130B
Total Assets $3.009B $2.750B $2.533B
YoY Change 9.4% 21.02% 16.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $18.60M $13.81M $9.970M
YoY Change 34.78% 12.62% 1.73%
Accrued Expenses $290.1M $241.8M $214.9M
YoY Change 19.98% 8.77% 12.99%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $100.0K $100.0K $100.0K
YoY Change 0.0% 0.0% -50.0%
Total Short-Term Liabilities $326.8M $268.3M $244.9M
YoY Change 21.8% 5.52% 13.85%
LONG-TERM LIABILITIES
Long-Term Debt $27.10M $144.2M $48.30M
YoY Change -81.21% 392.15% -4.17%
Other Long-Term Liabilities $200.4M $56.95M $55.86M
YoY Change 13.54% 4.41% -65.79%
Total Long-Term Liabilities $227.5M $56.95M $55.86M
YoY Change -29.06% 4.41% -73.86%
TOTAL LIABILITIES
Total Short-Term Liabilities $326.8M $268.3M $244.9M
Total Long-Term Liabilities $227.5M $56.95M $55.86M
Total Liabilities $665.7M $715.0M $583.9M
YoY Change -6.9% 32.0% 12.8%
SHAREHOLDERS EQUITY
Retained Earnings $1.247B $1.181B
YoY Change 23.95%
Common Stock $1.000M $498.0K
YoY Change 104.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.343B $2.035B $1.949B
YoY Change
Total Liabilities & Shareholders Equity $3.009B $2.750B $2.533B
YoY Change 9.4% 21.02% 16.2%

Cashflow Statement

Concept 2013 2012 Q4 2012 Q3
OPERATING ACTIVITIES
Net Income $280.5M $66.10M $65.91M
YoY Change 16.44% 13.27% 13.17%
Depreciation, Depletion And Amortization $39.97M $8.091M $7.925M
YoY Change 29.69% 11.35% 27.56%
Cash From Operating Activities $405.4M $105.2M $134.7M
YoY Change 24.77% 17.15% 34.57%
INVESTING ACTIVITIES
Capital Expenditures -$15.70M -$4.600M -$3.100M
YoY Change 8.28% 70.37% -40.38%
Acquisitions $238.0M
YoY Change -46.02%
Other Investing Activities -$247.8M -$246.6M -$131.3M
YoY Change -44.45% 201.47% 77.43%
Cash From Investing Activities -$263.5M -$251.1M -$134.4M
YoY Change -42.79% 196.81% 69.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $23.17M
YoY Change -180.41%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -132.1M 101.1M 53.70M
YoY Change -195.46% -551.34% -690.11%
NET CHANGE
Cash From Operating Activities 405.4M 105.2M 134.7M
Cash From Investing Activities -263.5M -251.1M -134.4M
Cash From Financing Activities -132.1M 101.1M 53.70M
Net Change In Cash 9.857M -44.80M 54.00M
YoY Change 267.25% 160.47% 357.63%
FREE CASH FLOW
Cash From Operating Activities $405.4M $105.2M $134.7M
Capital Expenditures -$15.70M -$4.600M -$3.100M
Free Cash Flow $421.1M $109.8M $137.8M
YoY Change 24.07% 18.7% 30.86%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
101265594 shares
CY2012Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
169799000
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
30.97
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q2 dei Entity Public Float
EntityPublicFloat
4551139349
CY2010Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
22290000
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
1447454000
CY2010Q4 us-gaap Malpractice Loss Contingency Accrual Undiscounted
MalpracticeLossContingencyAccrualUndiscounted
111662000
CY2010Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
421977000
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26251000
CY2011Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
16165000
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
1731016000
CY2011Q4 us-gaap Malpractice Loss Contingency Accrual Undiscounted
MalpracticeLossContingencyAccrualUndiscounted
122847000
CY2011Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
576030000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18596000
CY2011Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
9400000
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100038000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
101207000 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1961796 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
23.51
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3039288 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
101000
CY2012Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
9000000
CY2012Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
90600000
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
74051000
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
11603000
CY2012Q4 us-gaap Malpractice Loss Contingency Accrual Undiscounted Current
MalpracticeLossContingencyAccrualUndiscountedCurrent
17466000
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
787580000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
13812000
CY2012Q4 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
36176000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
268338000
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
13072000
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
160495000
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
56951000
CY2012Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
233000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
2035368000
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
624896000
CY2012Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
14700000
CY2012Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
22100000
CY2012Q4 us-gaap Malpractice Loss Contingency Accrual Undiscounted Noncurrent
MalpracticeLossContingencyAccrualUndiscountedNoncurrent
119570000
CY2012Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
144000000
CY2012Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
255661000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1246788000
CY2012Q4 us-gaap Assets
Assets
2750337000
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
46300000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
1000000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2750337000
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
125877000
CY2012Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
12000000
CY2012Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
12576000
CY2012Q4 us-gaap Capital Lease Obligations
CapitalLeaseObligations
334000
CY2012Q4 us-gaap Liabilities
Liabilities
714969000
CY2012Q4 us-gaap Malpractice Loss Contingency Accrual Undiscounted
MalpracticeLossContingencyAccrualUndiscounted
137036000
CY2012Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
624896000
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Assets Current
AssetsCurrent
359044000
CY2012Q4 us-gaap Goodwill
Goodwill
2165672000
CY2012Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
19787000
CY2012Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
104149000
CY2012Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
48200000
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
18444000
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
118290000
CY2012Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4852000
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
5624000
CY2012Q4 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
13800000
CY2012Q4 us-gaap Land
Land
6683000
CY2012Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
98503000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21280000
CY2012Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
872962000
CY2012Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
22957000
CY2012Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
-56843000
CY2012Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
11100000
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
248066000
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
43345000
CY2012Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
802000
CY2012Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
112956000
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
133789000
CY2012Q4 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
47593000
CY2012Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
14900000
CY2012Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
144800000
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
9228000
CY2012Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
6584000
CY2012Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
69034000
CY2012Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
509000
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
44232000
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
37.78
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
92000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
59738000
CY2012Q4 md Deferred Tax Liabilities Amortization
DeferredTaxLiabilitiesAmortization
136670000
CY2012Q4 md Accrued Professional Liability
AccruedProfessionalLiability
46400000
CY2012Q4 md Deferred Tax Liabilities Accrual To Cash Adjustment
DeferredTaxLiabilitiesAccrualToCashAdjustment
33129000
CY2012Q4 md Accrued Contingent Consideration Liability
AccruedContingentConsiderationLiability
16109000
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100038000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1941330 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
101207000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1519976 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
26.74
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1966170 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
7300000 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2013Q4 us-gaap Longterm Debt Weighted Average Interest Rate
LongtermDebtWeightedAverageInterestRate
0.009 pure
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
26.62
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
18989000
CY2013Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
8400000
CY2013Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
110300000
CY2013Q4 us-gaap Business Combination Contingent Consideration Arrangements Range Of Outcomes Value Low
BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow
0
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
86999000
CY2013Q4 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
100000
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
18150000
CY2013Q4 us-gaap Malpractice Loss Contingency Accrual Undiscounted Current
MalpracticeLossContingencyAccrualUndiscountedCurrent
19324000
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
857953000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
83047000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
18605000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
9843000
CY2013Q4 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
43403000
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
326792000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
9398000
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
14902000
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
189439000
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
60985000
CY2013Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
143000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
2342988000
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
712285000
CY2013Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
13400000
CY2013Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
23300000
CY2013Q4 us-gaap Malpractice Loss Contingency Accrual Undiscounted Noncurrent
MalpracticeLossContingencyAccrualUndiscountedNoncurrent
139367000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
6198000
CY2013Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
27000000
CY2013Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
308754000
CY2013Q4 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
767700000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1484023000
CY2013Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
200217000
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
70800000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
1012000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3049430000
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
152155000
CY2013Q4 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
100000
CY2013Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
8100000
CY2013Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
17946000
CY2013Q4 us-gaap Capital Lease Obligations
CapitalLeaseObligations
235000
CY2013Q4 us-gaap Liabilities
Liabilities
706442000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
14098000
CY2013Q4 us-gaap Malpractice Loss Contingency Accrual Undiscounted
MalpracticeLossContingencyAccrualUndiscounted
158691000
CY2013Q4 us-gaap Business Combination Contingent Consideration Arrangements Range Of Outcomes Value High
BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
14600000
CY2013Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
712285000
CY2013Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
14500000
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
24521000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
408839000
CY2013Q4 us-gaap Goodwill
Goodwill
2393731000
CY2013Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
25799000
CY2013Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
117246000
CY2013Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
29600000
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
16457000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
129438000
CY2013Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
6361000
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
6385000
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
25400000
CY2013Q4 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
17100000
CY2013Q4 us-gaap Land
Land
6683000
CY2013Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
103639000
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
8600000
CY2013Q4 us-gaap Assets
Assets
3049430000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31137000
CY2013Q4 md Line Of Credit Facility Potential Increase In Borrowing Capacity
LineOfCreditFacilityPotentialIncreaseInBorrowingCapacity
1000000000
CY2013Q4 md Deferred Tax Liabilities Accrual To Cash Adjustment
DeferredTaxLiabilitiesAccrualToCashAdjustment
37818000
CY2013Q4 md Line Of Credit Facility Reduction In Available Balance
LineOfCreditFacilityReductionInAvailableBalance
5300000
CY2013Q4 md Accrued Contingent Consideration Liability
AccruedContingentConsiderationLiability
19833000
CY2013Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
2 pure
CY2013Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
119542000
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
146910000
CY2013Q4 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
57511000
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
23800000
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
51900000
CY2013Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
16900000
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
174400000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
52400000
CY2013Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
997682000
CY2013Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
22981000
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
-80675000
CY2013Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
26300000
CY2013Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
5300000
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
285397000
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
20800000
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
52519000
CY2013Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
1310000
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
8007000
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
15500000
CY2013Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
6457000
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
9500000
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
71480000
CY2013Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
33000
CY2013Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
446000
CY2013Q4 us-gaap Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
111000000
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
42425000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
59911000
CY2013Q4 md Deferred Tax Liabilities Amortization
DeferredTaxLiabilitiesAmortization
162399000
CY2013Q4 md Accrued Professional Liability
AccruedProfessionalLiability
48400000
CY2011 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.23
CY2011 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
97592000 shares
CY2011 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3500 pure
CY2011 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.0044 pure
CY2011 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.28
CY2011 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.3829 pure
CY2011 us-gaap Malpractice Loss Contingency Period Increase Decrease
MalpracticeLossContingencyPeriodIncreaseDecrease
9843000
CY2011 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.0032 pure
CY2011 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
90000 shares
CY2011 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
31362000
CY2011 us-gaap Interest Paid Net
InterestPaidNet
2569000
CY2011 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
44000
CY2011 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3433000
CY2011 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0013 pure
CY2011 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2180000 shares
CY2011 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
270669000
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
35.50
CY2011 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
95412000 shares
CY2011 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0266 pure
CY2011 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
2541000
CY2011 us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
-3208028000
CY2011 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
751000
CY2011 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
119261000
CY2011 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
154885000
CY2011 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
630000000
CY2011 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
7100000
CY2011 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3932000
CY2011 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
31332000
CY2011 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
3362081000
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
355389000
CY2011 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
42526000
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
353245000
CY2011 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
48993000
CY2011 us-gaap Investment Income Net
InvestmentIncomeNet
1495000
CY2011 us-gaap Net Income Loss
NetIncomeLoss
217997000
CY2011 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
463000
CY2011 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
1588248000
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
27092000
CY2011 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
CY2011 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
7111000
CY2011 us-gaap Malpractice Loss Contingency Claims Incurred In Prior Periods
MalpracticeLossContingencyClaimsIncurredInPriorPeriods
11526000
CY2011 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
21480000
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
19000000
CY2011 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
20300000
CY2011 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
170356000
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-87751000
CY2011 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
38170000
CY2011 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
14472000
CY2011 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
CY2011 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
8063000
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
14100000
CY2011 us-gaap Malpractice Loss Contingency Claims Incurred Net
MalpracticeLossContingencyClaimsIncurredNet
11747000
CY2011 us-gaap Share Based Compensation
ShareBasedCompensation
27092000
CY2011 us-gaap Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
24500000
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-7655000
CY2011 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
13895000
CY2011 us-gaap Interest Expense
InterestExpense
3639000
CY2011 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
6704000
CY2011 us-gaap Malpractice Loss Contingency Claims Incurred In Period
MalpracticeLossContingencyClaimsIncurredInPeriod
221000
CY2011 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
31362000
CY2011 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
7486000
CY2011 md Line Of Credit Facility Payments For Amendment
LineOfCreditFacilityPaymentsForAmendment
1970000
CY2011 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
135248000
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-190573000
CY2011 us-gaap Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
7203000
CY2011 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1959000
CY2011 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
512500000
CY2011 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
577000
CY2011 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
25292000
CY2011 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
120776000
CY2011 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
7031000
CY2011 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
13000
CY2011 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10300000
CY2011 us-gaap Depreciation
Depreciation
15000000
CY2011 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
27100000
CY2011 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
20800000
CY2011 us-gaap Labor And Related Expense
LaborAndRelatedExpense
970396000
CY2011 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
1520000
CY2011 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
113290000
CY2011 us-gaap Operating Expenses
OperatingExpenses
1232859000
CY2011 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
400000
CY2011 md Provision Adjustment For Losses Related To Current Year
ProvisionAdjustmentForLossesRelatedToCurrentYear
33031000
CY2011 md Health Care Organization Patient Service Revenue Gross
HealthCareOrganizationPatientServiceRevenueGross
4851500000
CY2011 md Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
66815000
CY2011 md Hospital Contract Administrative Fees
HospitalContractAdministrativeFees
98829000
CY2011 md Payment Of Contingent Consideration Liability
PaymentOfContingentConsiderationLiability
350000
CY2011 md Provision Adjustment For Losses Related To Prior Year
ProvisionAdjustmentForLossesRelatedToPriorYear
-10099000
CY2011 md Payments Of Contingent Consideration Liabilities
PaymentsOfContingentConsiderationLiabilities
6211000
CY2011 md Contractual Adjustments And Uncollectibles
ContractualAdjustmentsAndUncollectibles
3362081000
CY2011 md Net Change In Fair Value Of Contingent Consideration Liabilities
NetChangeInFairValueOfContingentConsiderationLiabilities
1083000
CY2011 md Malpractice Loss Contingency Provision For Losses
MalpracticeLossContingencyProvisionForLosses
22932000
CY2013 dei Entity Registrant Name
EntityRegistrantName
MEDNAX, INC.
CY2013 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2013 dei Amendment Flag
AmendmentFlag
false
CY2013 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2013 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013 dei Document Type
DocumentType
10-K
CY2013 dei Document Period End Date
DocumentPeriodEndDate
2013-12-31
CY2013 dei Entity Central Index Key
EntityCentralIndexKey
0000893949
CY2013 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2013 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2013 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
27666 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
634882 shares
CY2013 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.78
CY2013 us-gaap Weighted Average Basic Shares Outstanding Pro Forma
WeightedAverageBasicSharesOutstandingProForma
99112000 shares
CY2013 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100969000 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
35.37
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3500 pure
CY2013 us-gaap Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
100969000 shares
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.0048 pure
CY2013 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.83
CY2013 us-gaap Nature Of Operations
NatureOfOperations
<div> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>1.&#xA0;&#xA0;&#xA0;&#xA0; General:</b></font></p> <!-- xbrl,body --> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The principal business activity of MEDNAX, Inc. (&#x201C;MEDNAX&#x201D; or the &#x201C;Company&#x201D;) and its subsidiaries is to provide neonatal, anesthesia, maternal-fetal and other pediatric subspecialties physician services. The Company has contracts with affiliated professional associations, corporations and partnerships (&#x201C;affiliated professional contractors&#x201D;), which are separate legal entities that provide physician services in certain states and Puerto Rico. The Company and its affiliated professional contractors also have contracts with hospitals and other healthcare facilities to provide physician services, which include (i)&#xA0;fee-for-service contracts, whereby hospitals agree, in exchange for the Company&#x2019;s services, to authorize the Company and its healthcare professionals to bill and collect the charges for medical services rendered by the Company&#x2019;s affiliated healthcare professionals, and (ii)&#xA0;administrative fee contracts, whereby the Company is assured a minimum revenue level.</font></p> </div>
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y
CY2013 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
2.90
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.3744 pure
CY2013 us-gaap Malpractice Loss Contingency Period Increase Decrease
MalpracticeLossContingencyPeriodIncreaseDecrease
19797000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
31.77
CY2013 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.0027 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0002 pure
CY2013 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1857000 shares
CY2013 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
2.85
CY2013 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
405398000
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
17.58
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
46.48
CY2013 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y4M24D
CY2013 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
99112000 shares
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1073118 shares
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0263 pure
CY2013 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
1100000 shares
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
35000 shares
CY2013 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Accounting Estimates and Assumptions</b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (&#x201C;GAAP&#x201D;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Significant estimates and assumptions are involved in the calculation of the Company&#x2019;s allowance for contractual adjustments and uncollectibles on accounts receivable, liabilities for self-insured amounts and claims incurred but not reported related to the Company&#x2019;s professional liability risks, the fair value of goodwill, and liabilities for uncertain tax positions. Actual results could differ from those estimates.</font></p> </div>
CY2013 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
228100000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
1049036 shares
CY2013 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P1Y7M6D
CY2013 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
28697000
CY2013 us-gaap Interest Paid Net
InterestPaidNet
3312000
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
338000
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-212000
CY2013 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
250100000
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
2955000
CY2013 us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
-4607843000
CY2013 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
CY2013 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
126411000
CY2013 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
236700000
CY2013 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
238045000
CY2013 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1028500000
CY2013 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
19000000
CY2013 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3541000
CY2013 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
15654000
CY2013 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
4695232000
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
452131000
CY2013 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
287918000
CY2013 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
2235170000
CY2013 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
20802000
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
448412000
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
37331000
CY2013 us-gaap Investment Income Net
InvestmentIncomeNet
1696000
CY2013 us-gaap Net Income Loss
NetIncomeLoss
280517000
CY2013 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
99000
CY2013 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
2154012000
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
31288000
CY2013 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
51863000
CY2013 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
18981000
CY2013 us-gaap Income Tax Reconciliation Tax Settlements
IncomeTaxReconciliationTaxSettlements
600000
CY2013 us-gaap Malpractice Loss Contingency Claims Incurred In Prior Periods
MalpracticeLossContingencyClaimsIncurredInPriorPeriods
10739000
CY2013 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
49239000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
33300000
CY2013 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
29800000
CY2013 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
38000
CY2013 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
28900000
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
218209000
CY2013 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-132051000
CY2013 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
43000000
CY2013 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
11011000
CY2013 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
18173000
CY2013 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
CY2013 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
15920000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
35400000
CY2013 us-gaap Malpractice Loss Contingency Claims Incurred Net
MalpracticeLossContingencyClaimsIncurredNet
11480000
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
31288000
CY2013 us-gaap Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
18900000
CY2013 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
51863000
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
9857000
CY2013 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
17037000
CY2013 us-gaap Interest Expense
InterestExpense
5415000
CY2013 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
5772000
CY2013 us-gaap Malpractice Loss Contingency Claims Incurred In Period
MalpracticeLossContingencyClaimsIncurredInPeriod
741000
CY2013 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
28697000
CY2013 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
14784000
CY2013 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-263490000
CY2013 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1211000
CY2013 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
911500000
CY2013 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
1136000
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
39966000
CY2013 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
149722000
CY2013 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
18579000
CY2013 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
24500000
CY2013 us-gaap Depreciation
Depreciation
15500000
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
31300000
CY2013 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
26400000
CY2013 us-gaap Labor And Related Expense
LaborAndRelatedExpense
1361318000
CY2013 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
1425000
CY2013 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
134938000
CY2013 us-gaap Operating Expenses
OperatingExpenses
1701881000
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
167895000
CY2013 md Line Of Credit Facility Payments For Amendment
LineOfCreditFacilityPaymentsForAmendment
CY2013 md Number Of Physician Group Practices
NumberOfPhysicianGroupPractices
11 Company
CY2013 md Business Acquisition Contingent Consideration At Fair Value Increase Decrease
BusinessAcquisitionContingentConsiderationAtFairValueIncreaseDecrease
1800000
CY2013 md Long Term Investment Maturity Minimum
LongTermInvestmentMaturityMinimum
P1Y
CY2013 md Provision Adjustment For Losses Related To Current Year
ProvisionAdjustmentForLossesRelatedToCurrentYear
41235000
CY2013 md Health Care Organization Patient Service Revenue Gross
HealthCareOrganizationPatientServiceRevenueGross
6702484000
CY2013 md Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
82388000
CY2013 md Increase In Uncertain Tax Position
IncreaseInUncertainTaxPosition
1800000
CY2013 md Hospital Contract Administrative Fees
HospitalContractAdministrativeFees
146760000
CY2013 md Time Period For Achievement Of Certain Performance Measures For Payment Of Contingent Consideration
TimePeriodForAchievementOfCertainPerformanceMeasuresForPaymentOfContingentConsideration
P5Y
CY2013 md Payment Of Contingent Consideration Liability
PaymentOfContingentConsiderationLiability
1308000
CY2013 md Long Term Investment Maturity Maximum
LongTermInvestmentMaturityMaximum
P7Y
CY2013 md Business Combination Contingent Consideration Arrangements Time Period
BusinessCombinationContingentConsiderationArrangementsTimePeriod
P5Y
CY2013 md Assumed Payment Probability Of Contingent Consideration Payment
AssumedPaymentProbabilityOfContingentConsiderationPayment
1.00 pure
CY2013 md Net Operating Loss Carry Forwards Expiration Date
NetOperatingLossCarryForwardsExpirationDate
2019
CY2013 md Provision Adjustment For Losses Related To Prior Year
ProvisionAdjustmentForLossesRelatedToPriorYear
-8100000
CY2013 md Payments Of Contingent Consideration Liabilities
PaymentsOfContingentConsiderationLiabilities
10365000
CY2013 md Contingent Consideration Payments Related To Prior Period Acquisitions
ContingentConsiderationPaymentsRelatedToPriorPeriodAcquisitions
13400000
CY2013 md Contractual Adjustments And Uncollectibles
ContractualAdjustmentsAndUncollectibles
4695232000
CY2013 md Net Change In Fair Value Of Contingent Consideration Liabilities
NetChangeInFairValueOfContingentConsiderationLiabilities
3656000
CY2013 md Business Acquisition Contingent Consideration At Fair Value Decrease
BusinessAcquisitionContingentConsiderationAtFairValueDecrease
900000
CY2013 md Business Acquisition Contingent Consideration At Fair Value Increase
BusinessAcquisitionContingentConsiderationAtFairValueIncrease
2700000
CY2013 md Malpractice Loss Contingency Provision For Losses
MalpracticeLossContingencyProvisionForLosses
33135000
CY2012 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
0.3794 pure
CY2012 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.42
CY2012 us-gaap Weighted Average Basic Shares Outstanding Pro Forma
WeightedAverageBasicSharesOutstandingProForma
97386000 shares
CY2012 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
99382000 shares
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3500 pure
CY2012 us-gaap Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
99382000 shares
CY2012 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.0015 pure
CY2012 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.47
CY2012 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
2.80
CY2012 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.3794 pure
CY2012 us-gaap Malpractice Loss Contingency Period Increase Decrease
MalpracticeLossContingencyPeriodIncreaseDecrease
9941000
CY2012 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.0036 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0013 pure
CY2012 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1996000 shares
CY2012 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
2.74
CY2012 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
324906000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
30.06
CY2012 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
97386000 shares
CY2012 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0260 pure
CY2012 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
58000 shares
CY2012 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
418900000
CY2012 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
28810000
CY2012 us-gaap Interest Paid Net
InterestPaidNet
2044000
CY2012 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
102000
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
244000
CY2012 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
451100000
CY2012 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
2478000
CY2012 us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
-3946058000
CY2012 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
CY2012 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
129636000
CY2012 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
436400000
CY2012 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
441006000
CY2012 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
402500000
CY2012 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
6200000
CY2012 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1153000
CY2012 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
14495000
CY2012 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
3994924000
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
389520000
CY2012 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
272657000
CY2012 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
2165561000
CY2012 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
33120000
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
388171000
CY2012 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
17678000
CY2012 us-gaap Investment Income Net
InvestmentIncomeNet
1896000
CY2012 us-gaap Net Income Loss
NetIncomeLoss
240907000
CY2012 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
136000
CY2012 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
1816612000
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
28437000
CY2012 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
CY2012 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
6198000
CY2012 us-gaap Malpractice Loss Contingency Claims Incurred In Prior Periods
MalpracticeLossContingencyClaimsIncurredInPriorPeriods
12564000
CY2012 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
16953000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
23000000
CY2012 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
24800000
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
193540000
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
138326000
CY2012 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
37700000
CY2012 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
28073000
CY2012 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
15510000
CY2012 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
CY2012 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
21344000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
18100000
CY2012 us-gaap Malpractice Loss Contingency Claims Incurred Net
MalpracticeLossContingencyClaimsIncurredNet
13133000
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
28437000
CY2012 us-gaap Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
20800000
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2684000
CY2012 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
13980000
CY2012 us-gaap Interest Expense
InterestExpense
3245000
CY2012 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-7343000
CY2012 us-gaap Malpractice Loss Contingency Claims Incurred In Period
MalpracticeLossContingencyClaimsIncurredInPeriod
569000
CY2012 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
28810000
CY2012 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
19814000
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-460548000
CY2012 us-gaap Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
3671000
CY2012 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
411000
CY2012 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
517500000
CY2012 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
1530000
CY2012 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
30816000
CY2012 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
131754000
CY2012 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
6494000
CY2012 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
15000000
CY2012 us-gaap Depreciation
Depreciation
15800000
CY2012 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
28400000
CY2012 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
23900000
CY2012 us-gaap Labor And Related Expense
LaborAndRelatedExpense
1130913000
CY2012 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
2002000
CY2012 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
111940000
CY2012 us-gaap Operating Expenses
OperatingExpenses
1427092000
CY2012 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
300000
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
147264000
CY2012 md Line Of Credit Facility Payments For Amendment
LineOfCreditFacilityPaymentsForAmendment
2397000
CY2012 md Number Of Physician Group Practices
NumberOfPhysicianGroupPractices
16 Company
CY2012 md Provision Adjustment For Losses Related To Current Year
ProvisionAdjustmentForLossesRelatedToCurrentYear
35441000
CY2012 md Health Care Organization Patient Service Revenue Gross
HealthCareOrganizationPatientServiceRevenueGross
5691790000
CY2012 md Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
71823000
CY2012 md Hospital Contract Administrative Fees
HospitalContractAdministrativeFees
119746000
CY2012 md Payment Of Contingent Consideration Liability
PaymentOfContingentConsiderationLiability
786000
CY2012 md Decrease In Uncertain Tax Position
DecreaseInUncertainTaxPosition
3100000
CY2012 md Provision Adjustment For Losses Related To Prior Year
ProvisionAdjustmentForLossesRelatedToPriorYear
-8119000
CY2012 md Payments Of Contingent Consideration Liabilities
PaymentsOfContingentConsiderationLiabilities
9445000
CY2012 md Contractual Adjustments And Uncollectibles
ContractualAdjustmentsAndUncollectibles
3994924000
CY2012 md Net Change In Fair Value Of Contingent Consideration Liabilities
NetChangeInFairValueOfContingentConsiderationLiabilities
995000
CY2012 md Malpractice Loss Contingency Provision For Losses
MalpracticeLossContingencyProvisionForLosses
27322000
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.55
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100784000 shares
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
98618000 shares
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
91552000
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
90765000
CY2013Q1 us-gaap Investment Income Net
InvestmentIncomeNet
402000
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
55367000
CY2013Q1 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
502715000
CY2013Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
53318000
CY2013Q1 us-gaap Interest Expense
InterestExpense
1189000
CY2013Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9144000
CY2013Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
329201000
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
411163000
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
35398000
CY2013Q1 md Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
19500000
CY2012Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.49
CY2012Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
98798000 shares
CY2012Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.50
CY2012Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
96538000 shares
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
79388000
CY2012Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
79262000
CY2012Q1 us-gaap Investment Income Net
InvestmentIncomeNet
428000
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
48350000
CY2012Q1 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
422616000
CY2012Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
46869000
CY2012Q1 us-gaap Interest Expense
InterestExpense
554000
CY2012Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7113000
CY2012Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
272261000
CY2012Q1 us-gaap Operating Expenses
OperatingExpenses
343228000
CY2012Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30912000
CY2012Q1 md Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
16985000
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.61
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
99090000 shares
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.62
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
97086000 shares
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
99736000
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
99253000
CY2012Q2 us-gaap Investment Income Net
InvestmentIncomeNet
365000
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
60544000
CY2012Q2 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
449530000
CY2012Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
48200000
CY2012Q2 us-gaap Interest Expense
InterestExpense
848000
CY2012Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7687000
CY2012Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
275951000
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
349794000
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38709000
CY2012Q2 md Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
17956000
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.68
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101098000 shares
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.70
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
99116000 shares
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
113371000
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
112094000
CY2013Q2 us-gaap Investment Income Net
InvestmentIncomeNet
396000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
69218000
CY2013Q2 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
529180000
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
54601000
CY2013Q2 us-gaap Interest Expense
InterestExpense
1673000
CY2013Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9870000
CY2013Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
331922000
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
415809000
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
42876000
CY2013Q2 md Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
19416000
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.66
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
99618000 shares
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.67
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
97876000 shares
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
107373000
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
107171000
CY2012Q3 us-gaap Investment Income Net
InvestmentIncomeNet
422000
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
65910000
CY2012Q3 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
473134000
CY2012Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
48200000
CY2012Q3 us-gaap Interest Expense
InterestExpense
624000
CY2012Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7925000
CY2012Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
292030000
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
365761000
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
41261000
CY2012Q3 md Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
17606000
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.76
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101178000 shares
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.77
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
99506000 shares
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
123291000
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
122156000
CY2013Q3 us-gaap Investment Income Net
InvestmentIncomeNet
372000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
76958000
CY2013Q3 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
554730000
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
54654000
CY2013Q3 us-gaap Interest Expense
InterestExpense
1507000
CY2013Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10461000
CY2013Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
346879000
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
431439000
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
45198000
CY2013Q3 md Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
19445000
CY2012Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.66
CY2012Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100212000 shares
CY2012Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.67
CY2012Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
98226000 shares
CY2012Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
103023000
CY2012Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
102485000
CY2012Q4 us-gaap Investment Income Net
InvestmentIncomeNet
681000
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
66103000
CY2012Q4 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
471332000
CY2012Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
50271000
CY2012Q4 us-gaap Interest Expense
InterestExpense
1219000
CY2012Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8091000
CY2012Q4 us-gaap Labor And Related Expense
LaborAndRelatedExpense
290671000
CY2012Q4 us-gaap Operating Expenses
OperatingExpenses
368309000
CY2012Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
36382000
CY2012Q4 md Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
19276000
CY2013Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.78
CY2013Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101080000 shares
CY2013Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.79
CY2013Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
99469000 shares
CY2013Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
123917000
CY2013Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
123397000
CY2013Q4 us-gaap Investment Income Net
InvestmentIncomeNet
526000
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
78974000
CY2013Q4 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
567387000
CY2013Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
55636000
CY2013Q4 us-gaap Interest Expense
InterestExpense
1046000
CY2013Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10491000
CY2013Q4 us-gaap Labor And Related Expense
LaborAndRelatedExpense
353316000
CY2013Q4 us-gaap Operating Expenses
OperatingExpenses
443470000
CY2013Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
44423000
CY2013Q4 md Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
24027000

Files In Submission

Name View Source Status
0001193125-14-045903-index-headers.html Edgar Link pending
0001193125-14-045903-index.html Edgar Link pending
0001193125-14-045903.txt Edgar Link pending
0001193125-14-045903-xbrl.zip Edgar Link pending
d661956d10k.htm Edgar Link pending
d661956dex211.htm Edgar Link pending
d661956dex231.htm Edgar Link pending
d661956dex31.htm Edgar Link pending
d661956dex311.htm Edgar Link pending
d661956dex312.htm Edgar Link pending
d661956dex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g661956g48w32.jpg Edgar Link pending
md-20131231.xml Edgar Link completed
md-20131231.xsd Edgar Link pending
md-20131231_cal.xml Edgar Link unprocessable
md-20131231_def.xml Edgar Link unprocessable
md-20131231_lab.xml Edgar Link unprocessable
md-20131231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending